Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results (vol 9, pg 898, 2023)

被引：1

作者：

Glitza Oliva, Isabella C. ^{[1
]}

Ferguson, Sherise D. ^{[2
]}

Bassett, Roland ^{[3
]}

Foster, Alexandra P. ^{[1
]}

John, Ida ^{[1
]}

Hennegan, Tarin D. ^{[1
]}

Rohlfs, Michelle ^{[1
]}

Richard, Jessie ^{[1
]}

Iqbal, Masood ^{[1
]}

Dett, Tina ^{[1
]}

Lacey, Carol ^{[1
]}

Jackson, Natalie ^{[1
]}

Rodgers, Theresa ^{[1
]}

Phillips, Suzanne ^{[1
]}

Duncan, Sheila ^{[4
]}

Haydu, Lauren ^{[4
]}

Lin, Ruitao ^{[1
,3
]}

Amaria, Rodabe N. ^{[1
]}

Wong, Michael K. ^{[1
]}

Diab, Adi ^{[1
]}

Yee, Cassian ^{[1
]}

Patel, Sapna P. ^{[1
]}

Mcquade, Jennifer L. ^{[1
]}

Fischer, Grant M. ^{[1
]}

Mccutcheon, Ian E. ^{[2
]}

O'Brien, Barbara J. ^{[5
]}

Tummala, Sudhakar ^{[5
]}

Debnam, Matthew ^{[6
]}

Guha-Thakurta, Nandita ^{[6
]}

Wargo, Jennifer A. ^{[4
]}

Carapeto, Fernando C. L. ^{[7
]}

Hudgens, Courtney W. ^{[7
]}

Huse, Jason T. ^{[8
]}

Tetzlaff, Michael T. ^{[9
]}

Burton, Elizabeth M. ^{[10
]}

Tawbi, Hussein A. ^{[1
]}

Davies, Michael A. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX USA

[6] Univ Texas MD Anderson Canc Ctr, Dept Neuroradiol, Houston, TX USA

[7] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77054 USA

[8] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX USA

[9] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA

[10] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77054 USA

来源：

NATURE MEDICINE | 2024年 / 30卷 / 06期

关键词：

D O I：

10.1038/s41591-024-02998-5

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1787 / 1787

页数：1

共 50 条

[1] Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results
Glitza Oliva, Isabella C.
Ferguson, Sherise D.
Bassett Jr, Roland
Foster, Alexandra P.
John, Ida
Hennegan, Tarin D.
Rohlfs, Michelle
Richard, Jessie
Iqbal, Masood
Dett, Tina
Lacey, Carol
Jackson, Natalie
Rodgers, Theresa
Phillips, Suzanne
Duncan, Sheila
Haydu, Lauren
Lin, Ruitao
Amaria, Rodabe N.
Wong, Michael K.
Diab, Adi
Yee, Cassian
Patel, Sapna P.
McQuade, Jennifer L.
Fischer, Grant M.
McCutcheon, Ian E.
O'Brien, Barbara J.
Tummala, Sudhakar
Debnam, Matthew
Guha-Thakurta, Nandita
Wargo, Jennifer A.
Burton, Elizabeth M.
Tawbi, Hussein A.
Davies, Michael A.
NATURE MEDICINE, 2023, 29 (04) : 898 - 905
[2] Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results
Isabella C. Glitza Oliva
Sherise D. Ferguson
Roland Bassett
Alexandra P. Foster
Ida John
Tarin D. Hennegan
Michelle Rohlfs
Jessie Richard
Masood Iqbal
Tina Dett
Carol Lacey
Natalie Jackson
Theresa Rodgers
Suzanne Phillips
Sheila Duncan
Lauren Haydu
Ruitao Lin
Rodabe N. Amaria
Michael K. Wong
Adi Diab
Cassian Yee
Sapna P. Patel
Jennifer L. McQuade
Grant M. Fischer
Ian E. McCutcheon
Barbara J. O’Brien
Sudhakar Tummala
Matthew Debnam
Nandita Guha-Thakurta
Jennifer A. Wargo
Fernando C. L. Carapeto
Courtney W. Hudgens
Jason T. Huse
Michael T. Tetzlaff
Elizabeth M. Burton
Hussein A. Tawbi
Michael A. Davies
Nature Medicine, 2023, 29 : 898 - 905
[3] Concurrent intrathecal (IT) and intravenous (IV) nivolumab (N) for melanoma (MM) patients (pts) with leptomeningeal disease (LMD)
Glitza, I. C.
Phillips, S.
John, I.
Bassett, R. L.
Lin, R.
Rohlfs, M. L.
Richard, J.
Iqbal, M.
Hennegan, T.
McCutcheon, I. E.
Ferguson, S.
O'Brien, B.
Tummala, S.
Guha-Thakurta, N.
Debnam, M.
Tawbi, H. A.
Burton, E.
Davies, M.
ANNALS OF ONCOLOGY, 2023, 34 : S652 - S652
[4] A phase I/Ib study of concurrent intravenous (IV) and intrathecal (IT) nivolumab (Nivo) for melanoma patients (pts) with leptomeningeal disease (LMD)
Glitza, I. C.
Rohlfs, M. L.
Iqbal, M.
Richard, J.
Burton, E.
Duncan, S.
Brown, C.
Anderson, J.
Hwu, P.
Hwu, W-J.
Wong, M.
Yee, C.
Patel, S.
Woodman, S.
Amaria, R.
Diab, A.
Tawbi, H.
Davies, M.
ANNALS OF ONCOLOGY, 2018, 29
[5] Single-center phase I/Ib study of concurrent intrathecal (IT) and intravenous (IV) nivolumab (N) for metastatic melanoma (MM) patients (pts) with leptomeningeal disease (LMD).
Glitza, Isabella Claudia
Phillips, Suzanne
Brown, Courtney
Haymaker, Cara L.
Bassett, Roland L.
Lee, J. Jack
Rohlfs, Michelle L.
Richard, Jessie
Iqbal, Masood
John, Ida
McCutcheon, Ian E.
Ferguson, Sherise D.
Heimberger, Amy B.
O'Brien, Barbara Jane
Tummala, Sudhakar
Guha-Thakurta, Nandita
Debnam, Matthew
Burton, Elizabeth M.
Tawbi, Hussein Abdul-Hassan
Davies, Michael A.
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[6] Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results (vol 29, pg 1379, 2023)
Heczey, Andras
Xu, Xin
Courtney, Amy N.
Tian, Gengwen
Barragan, Gabriel A.
Guo, Linjie
Amador, Claudia Martinez
Ghatwai, Nisha
Rathi, Purva
Wood, Michael S.
Li, Yanchuan
Zhang, Chunchao
Demberg, Thorsten
Di Pierro, Erica J.
Sher, Andrew C.
Zhang, Huimin
Mehta, Birju
Thakkar, Sachin G.
Grilley, Bambi
Wang, Tao
Weiss, Brian D.
Montalbano, Antonino
Subramaniam, Meena
Xu, Chenling
Sachar, Chirag
Wells, Daniel K.
Dotti, Gianpietro
Metelitsa, Leonid S.
NATURE MEDICINE, 2024, 30 (04) : 1210 - 1210
[7] Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial (vol 29, pg 2835, 2023)
Kirkwood, John M.
Del Vecchio, Michele
Weber, Jeffrey
Hoeller, Christoph
Grob, Jean-Jacques
Mohr, Peter
Loquai, Carmen
Dutriaux, Caroline
Chiarion-Sileni, Vanna
Mackiewicz, Jacek
Rutkowski, Piotr
Arenberger, Petr
Quereux, Gaelle
Meniawy, Tarek M.
Ascierto, Paolo A.
Menzies, Alexander M.
Durani, Piyush
Lobo, Maurice
Campigotto, Federico
Gastman, Brian
Long, Georgina V.
NATURE MEDICINE, 2024, 30 (03) : 906 - 906
[8] Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results (vol 29, 422, 2023)
Mailankody, Sham
Matous, Jeffrey V.
Chhabra, Saurabh
Liedtke, Michaela
Sidana, Surbhi
Oluwole, Olalekan O.
Malik, Shahbaz
Nath, Rajneesh
Anwer, Faiz
Cruz, Jose Carlos
Htut, Myo
Karski, Erin E.
Lovelace, Wade
Dillon, Myles
Butz, Eric
Ying, Wendy
Balakumaran, Arun
Kumar, Shaji K.
NATURE MEDICINE, 2023, 29 (12) : 3271 - 3271
[9] AADC Gene Therapy for Advanced Parkinson's Disease: Interim Results of a Phase 1b Trial
Ravina, Bernard
Christine, Chadwick W.
Larson, Paul S.
Van Laar, Amber
Richardson, R. Mark
Kells, Adrian
Boot, Brendon
Martin, Alastair
Thompson, Marin
Bankiewicz, Krystof S.
MOLECULAR THERAPY, 2018, 26 (05) : 32 - 32
[10] Radiation Therapy Followed by Intrathecal Trastuzumab-Pertuzumab for ERBB2-Positive Breast Leptomeningeal Disease: A Phase 1 Nonrandomized Controlled Trial
Ahmed, Kamran A.
Kumthekar, Priya U.
Pina, Yolanda
Kim, Youngchul
Vogelbaum, Michael A.
Han, Hyo S.
Forsyth, Peter A.
JAMA ONCOLOGY, 2024, 10 (07) : 984 - 986

← 1 2 3 4 5 →